This document is an excerpt from the EUR-Lex website
Document 62021TN0678
Case T-678/21: Action brought on 19 October 2021 — Mendes v EUIPO — Actial Farmaceutica (VSL3TOTAL)
Case T-678/21: Action brought on 19 October 2021 — Mendes v EUIPO — Actial Farmaceutica (VSL3TOTAL)
Case T-678/21: Action brought on 19 October 2021 — Mendes v EUIPO — Actial Farmaceutica (VSL3TOTAL)
OJ C 502, 13.12.2021, p. 41–41
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
13.12.2021 |
EN |
Official Journal of the European Union |
C 502/41 |
Action brought on 19 October 2021 — Mendes v EUIPO — Actial Farmaceutica (VSL3TOTAL)
(Case T-678/21)
(2021/C 502/61)
Language of the case: English
Parties
Applicant: Mendes SA (Lugano, Switzerland) (represented by: M. Cavattoni, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Actial Farmaceutica Srl (Rome, Italy)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Applicant before the General Court
Trade mark at issue: European Union word mark VSL3TOTAL — European Union trade mark No 11 702 172
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 17 August 2021 in Case R 1568/2020-2
Form of order sought
The applicant claims that the Court should:
|
— |
uphold the present action; |
|
— |
annul the contested decision; |
|
— |
condemn the other party in the proceedings to bear the costs and fees. |
Plea in law
|
— |
Infringement of Article 60(1)(a) in conjunction with Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |